Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 37
2021 40
2022 27
2023 10
2024 15
2025 8
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Patients Suffering From Post-COVID-19 Syndrome Feature Enhanced Antibody Reactivity Towards Specific Linear Epitopes Within EBV EBNA1.
Lorenz P, Steinbeck F, Fricke F, Mai F, Bergmann-Ewert W, Wossidlo C, Reisinger EC, Müller-Hilke B. Lorenz P, et al. Scand J Immunol. 2026 Jan;103(1):e70088. doi: 10.1111/sji.70088. Scand J Immunol. 2026. PMID: 41518079 Free PMC article.
Post-COVID-19 syndrome (PCS; also known as post-acute sequelae of COVID-19, PASC and Long COVID) manifests with various clinical symptoms of unclear aetiology that persist or develop months after acute infection with SARS-CoV-2 …
Post-COVID-19 syndrome (PCS; also known as post-acute sequelae of COVID-19, PASC and Long COVID) manifest …
Comparing the clinical outcomes of Remdesivir and Interferon beta-1a in hospitalized COVID-19 patients: A cross-sectional retrospective single-center study.
Asgari M, Kousha A, Ghaffari ME, Yaghubi Kalurazi T, Zaminy A. Asgari M, et al. J Infect Dev Ctries. 2025 Nov 30;19(11):1606-1614. doi: 10.3855/jidc.20584. J Infect Dev Ctries. 2025. PMID: 41358767 Free article.
INTRODUCTION: The effectiveness of remdesivir (RDV) and interferon beta-1a (IFNbeta-1a) was assessed and compared in patients hospitalized with coronavirus disease of 2019 (COVID-19). METHODOLOGY: A total of 162 hospitalized COVID-19 patients we …
INTRODUCTION: The effectiveness of remdesivir (RDV) and interferon beta-1a (IFNbeta-1a) was assessed and compared in patients hospita …
COVID-19 Patients with Kidney Disease and Completion of Remdesivir Treatment.
Lee W, Fogel J, Shalmiyev A, Huang G, George T, Okoye C, Yusuf Y, Kozlov M, El-Hennawy A, Frolova E. Lee W, et al. South Med J. 2025 Nov;118(11):699-703. doi: 10.14423/SMJ.0000000000001901. South Med J. 2025. PMID: 41191440
OBJECTIVES: Remdesivir is a nucleotide analog used to treat coronavirus disease 2019 (COVID-19). We determined whether reduced kidney function is associated with the completion of a full course of remdesivir in hospitalized patients with COVID-19. METH …
OBJECTIVES: Remdesivir is a nucleotide analog used to treat coronavirus disease 2019 (COVID-19). We determined whether reduced …
Uncovering potent natural phytochemicals targeting SARS-COV-2 spike protein variants: molecular dynamics insights.
Sevimoglu T, Kızılpınar E, Çalışkaner ZO, Zengin İN. Sevimoglu T, et al. Sci Rep. 2025 Oct 30;15(1):37927. doi: 10.1038/s41598-025-25242-7. Sci Rep. 2025. PMID: 41168466 Free PMC article.
SARS-CoV-2 remains a critical global health concern due to its high transmissibility, evolving variants, and the absence of a universally effective treatment. ...Overall, the study highlights betulinic acid and beta-sitosterol as presumptive SARS …
SARS-CoV-2 remains a critical global health concern due to its high transmissibility, evolving variants, and the absenc …
Characterization of the Binding and Inhibition Mechanisms of a Novel Neutralizing Monoclonal Antibody Targeting the Stem Helix Region in the S2 Subunit of the Spike Protein of SARS-CoV-2.
Tan SSE, Tam EH, Lai KM, Wu Y, Xiao T, Tan YJ. Tan SSE, et al. Vaccines (Basel). 2025 Jun 26;13(7):688. doi: 10.3390/vaccines13070688. Vaccines (Basel). 2025. PMID: 40733665 Free PMC article.
The S1 domain acquired multiple mutations as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolved to give rise to Variant of Concerns (VOCs) but the S2 domain has limited changes. In particular, the stem helix in S2 did not change signific …
The S1 domain acquired multiple mutations as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolved t …
Synthetic host defense peptide inhibits SARS-CoV-2 replication in vitro.
Harfoot R, Lawley B, Hernández LC, Kuang J, Hills FR, Sinha S, Allais MJM, Bird TW, Hird CP, Taylor JA, Bostina M, Comoletti D, Haney EF, Hancock REW, Pletzer D, Quiñones-Mateu ME. Harfoot R, et al. Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0170024. doi: 10.1128/aac.01700-24. Epub 2025 Jun 23. Antimicrob Agents Chemother. 2025. PMID: 40548715 Free PMC article.
Although myriads of potential antiviral agents have been tested against SARS-CoV-2, only a handful have proven to be effective in clinical trials. During the COVID-19 pandemic, many known or novel peptides were evaluated for their ability to inh …
Although myriads of potential antiviral agents have been tested against SARS-CoV-2, only a handful have proven to be ef …
Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh.
Afroze F, Begum MN, Ahmed T, El Arifeen S, Rahman MZ, Rahman AE, Mahfuz M, Kabir MF, Kabir A, Amin R, Uddin MS, Asaduzzaman M, Hasnat MA, Islam K, Sharif M, Hossain R, Jahan Y, Rahman M, Chisti MJ. Afroze F, et al. J Glob Health. 2024 Jun 21;14:05009. doi: 10.7189/jogh.14.05009. J Glob Health. 2024. PMID: 40057834 Free PMC article.
We collected data prospectively between 1 July 2021 and 30 September 2021 (delta) and retrospectively from 1 November 2020 to 4 March 2021 (ancestral), 5 March 2021 to 30 May 2021 (alpha/beta), and 1 January 2022 to 28 February 2022 (omicron), with the periods representing …
We collected data prospectively between 1 July 2021 and 30 September 2021 (delta) and retrospectively from 1 November 2020 to 4 March 2021 ( …
Examining the bias-efficiency tradeoff from incorporation of nonconcurrent controls in platform trials: A simulation study example from the adaptive COVID-19 treatment trial.
Bonnett T, Potter GE, Dodd LE. Bonnett T, et al. Clin Trials. 2025 Aug;22(4):471-481. doi: 10.1177/17407745251313928. Epub 2025 Feb 8. Clin Trials. 2025. PMID: 39921419
However, there has been limited exploration of the degree of type I error inflation one can plausibly expect in real-world scenarios. METHODS: We use data from the Adaptive COVID-19 Treatment Trial (ACTT) to mimic a realistic platform trial with a remdesivir control …
However, there has been limited exploration of the degree of type I error inflation one can plausibly expect in real-world scenarios. METHOD …
Repetitive stability study of remdesivir/cyclodextrin complex on the international space station.
Dormán G, Buchholcz B, Puskás I, Szabó P, Varga E, Szente L, Keserű GM, Darvas F. Dormán G, et al. Sci Rep. 2025 Feb 4;15(1):4182. doi: 10.1038/s41598-024-81428-5. Sci Rep. 2025. PMID: 39905100 Free PMC article.
Therefore, we investigated the stability of an anti-Covid drug formulation, Remdesivir (RDV) sulfobutylether-beta-cyclodextrin (SBECD) complex, in two separate flight experiments on the International Space Station (ISS). ...
Therefore, we investigated the stability of an anti-Covid drug formulation, Remdesivir (RDV) sulfobutylether-beta-cyclodextrin …
A combined proteomic and metabolomic analysis of the early aborted embryonic tissues with maternal COVID-19 infection.
Ling L, Xu G, Fang M, Chen J, Gong M, Wang T, Ju R, Nie S. Ling L, et al. J Proteomics. 2025 Mar 20;313:105383. doi: 10.1016/j.jprot.2025.105383. Epub 2025 Jan 8. J Proteomics. 2025. PMID: 39793701
Our findings provide a network of protein regulation and metabolite perturbation during early embryonic development with COVID-19 infection. Our findings can provide valuable insights for further exploration of the complex mechanism of COVID-19-associa …
Our findings provide a network of protein regulation and metabolite perturbation during early embryonic development with COVID-19 …
120 results